Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising effects. However, the cost of this innovative drug and its supply have become key topics for patients and healthcare providers. While tirzepatide has been cleared by regulatory agencies, its costly nature presents a significant barrier to many. Discussions